PPAR agonists
US10550071B2 · kind B2 · utility
1Cited by
2References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 15, 2018 |
| Grant date | Feb 4, 2020 |
| Priority date | — |
| Expiry date | Feb 15, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds and compositions useful in increasing PPARδ activity. The compounds and compositions provided herein are useful for the treatment of PPARδ related diseases (e.g., muscular diseases, vascular disease, demyelinating disease, and metabolic diseases).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.